108 related articles for article (PubMed ID: 31012004)
1. A Novel Dipeptide Ligand of TSPO.
Deeva OA; Pantileev AS; Rybina IV; Yarkova MA; Gudasheva TA; Seredenin SB
Dokl Biochem Biophys; 2019 May; 484(1):17-20. PubMed ID: 31012004
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
[TBL] [Abstract][Full Text] [Related]
3. The New Dipeptide TSPO Ligands: Design, Synthesis and Structure-Anxiolytic Activity Relationship.
Gudasheva TA; Deeva OA; Pantileev AS; Mokrov GV; Rybina IV; Yarkova MA; Seredenin SB
Molecules; 2020 Nov; 25(21):. PubMed ID: 33158242
[TBL] [Abstract][Full Text] [Related]
4. The first dipeptide ligand of translocator protein: Design and anxiolytic activity.
Gudasheva TA; Deeva OA; Mokrov GV; Yarkov SA; Yarkova MA; Seredenin SB
Dokl Biochem Biophys; 2015; 464():290-3. PubMed ID: 26518550
[TBL] [Abstract][Full Text] [Related]
5. Dependence of anxiolytic effects of the dipeptide TSPO ligand GD-23 on neurosteroid biosynthesis.
Gudasheva TA; Deeva OA; Yarkova MA; Seredenin SB
Dokl Biochem Biophys; 2016 Jul; 469(1):298-301. PubMed ID: 27599516
[TBL] [Abstract][Full Text] [Related]
6. The Novel Dipeptide Translocator Protein Ligand, Referred to As GD-23, Exerts Anxiolytic and Nootropic Activities.
Povarnina PY; Yarkov SA; Gudasheva TA; Yarkova MA; Seredenin SB
Acta Naturae; 2015; 7(3):108-12. PubMed ID: 26483966
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and anxiolytic-like activity of 1-arylpyrrolo[1,2-a]pyrazine-3-carboxamides.
Mokrov GV; Deeva OA; Gudasheva TA; Yarkov SA; Yarkova MA; Seredenin SB
Bioorg Med Chem; 2015 Jul; 23(13):3368-78. PubMed ID: 25937237
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel β-lactoglobulin-derived peptides, wheylin-1 and -2, having anxiolytic-like activity in mice.
Yamada A; Mizushige T; Kanamoto R; Ohinata K
Mol Nutr Food Res; 2014 Feb; 58(2):353-8. PubMed ID: 24039078
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Pharmacological Activity of New Pyrrolo[1,2-A] Pyrazine Translocator Protein (TSPO) Ligands.
Mokrov G; Pantileev A; Yarkova M; Gudasheva T; Seredenin S
Med Chem; 2022; 18(4):497-508. PubMed ID: 34365957
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity.
Costa B; Da Pozzo E; Chelli B; Simola N; Morelli M; Luisi M; Maccheroni M; Taliani S; Simorini F; Da Settimo F; Martini C
Psychoneuroendocrinology; 2011 May; 36(4):463-72. PubMed ID: 20728278
[TBL] [Abstract][Full Text] [Related]
11. Anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in animal models of post-traumatic stress disorder.
Zhang LM; Qiu ZK; Zhao N; Chen HX; Liu YQ; Xu JP; Zhang YZ; Yang RF; Li YF
Int J Neuropsychopharmacol; 2014 Oct; 17(10):1659-69. PubMed ID: 24763106
[TBL] [Abstract][Full Text] [Related]
12. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
Qiu ZK; Zhang LM; Zhao N; Chen HX; Zhang YZ; Liu YQ; Mi TY; Zhou WW; Li Y; Yang RF; Xu JP; Li YF
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():40-6. PubMed ID: 23624119
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa).
Zhang LM; Zhao N; Guo WZ; Jin ZL; Qiu ZK; Chen HX; Xue R; Zhang YZ; Yang RF; Li YF
Neuropharmacology; 2014 Jun; 81():116-25. PubMed ID: 24067925
[TBL] [Abstract][Full Text] [Related]
14. [Design and synthesis of cholecystokinin-4 dipeptide analogues with anxiolytic and anxiogenic activities].
Gudasheva TA; Kir'ianova EP; Kolik LG; Konstantinopol'skiĭ MA; Seredenin SB
Bioorg Khim; 2007; 33(4):413-20. PubMed ID: 17886432
[TBL] [Abstract][Full Text] [Related]
15. TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance.
Costa B; Da Pozzo E; Giacomelli C; Taliani S; Bendinelli S; Barresi E; Da Settimo F; Martini C
Apoptosis; 2015 Mar; 20(3):383-98. PubMed ID: 25413799
[TBL] [Abstract][Full Text] [Related]
16. [EXPERIMENTAL PHARMACOKINETICS AND PHARMACODYNAMICS OF GB-115 DIPEPTIDE ANXIOLYTIC SUBSTANCES].
Kolik LG; Zherdev VP; Boiko SS; Konstantinopol'skii MA; Raskin SY; Gudasheva TA; Mart'yanov VA; Seredenin SB
Eksp Klin Farmakol; 2015; 78(11):30-4. PubMed ID: 27017703
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the 18 kDa translocator protein (TSPO) in the hippocampal dentate gyrus produced anxiolytic and antidepressant-like behavioural effects.
Li L; Wang W; Zhang LM; Jiang XY; Sun SZ; Sun LJ; Guo Y; Gong J; Zhang YZ; Wang HL; Li YF
Neuropharmacology; 2017 Oct; 125():117-128. PubMed ID: 28655607
[TBL] [Abstract][Full Text] [Related]
18. Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects.
Simorini F; Marini AM; Taliani S; La Motta C; Salerno S; Pugliesi I; Da Settimo F
Curr Top Med Chem; 2012; 12(4):333-51. PubMed ID: 22204487
[TBL] [Abstract][Full Text] [Related]
19. Modified benzoxazolone derivative as 18-kDa TSPO ligand.
Kumari N; Chadha N; Srivastava P; Mishra LC; Bhagat S; Mishra AK; Tiwari AK
Chem Biol Drug Des; 2017 Oct; 90(4):511-519. PubMed ID: 28267890
[TBL] [Abstract][Full Text] [Related]
20. TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy.
Costa B; Da Pozzo E; Giacomelli C; Barresi E; Taliani S; Da Settimo F; Martini C
Sci Rep; 2016 Jan; 6():18164. PubMed ID: 26750656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
